Cancer Channel
Related Channels

Kyprolis Uses

Adults who have a type of cancer called multiple myeloma may receive Kyprolis. This drug is used when at least two other treatments have been tried but the cancer has progressed and become worse during or within 60 days of stopping the other medicines. As a type of proteasome inhibitor, Kyprolis works by causing proteins to build up in the cancer cells, which causes them to die.


What Is Kyprolis Used For?

Kyprolis™ (carfilzomib) is an injectable prescription medication approved to treat adults with multiple myeloma. It is approved for use in people who have already received at least two other treatments. Kyprolis belongs to a group of medicines known as proteasome inhibitors.
Multiple myeloma is a type of blood cancer that affects plasma cells. Plasma cells are a kind of white blood cell that makes antibodies, which are part of the immune system. Antibodies recognize and attach to substances found on certain germs and other harmful substances, marking them for destruction by the immune system.
Plasma cells are made in the bone marrow, the soft spongy middle part of many of the bones in the body. In multiple myeloma, the plasma cells become abnormal. The abnormal plasma cells, called myeloma cells, grow out of control, build up in the bone marrow, and form tumors in the solid part of the bone.
The tumors caused by myeloma cells can make it difficult for the bone marrow to produce normal, healthy blood cells. This can lead to problems such as anemia (from low red blood cell counts) and easy bleeding and bruising (from low platelet counts). The myeloma cells also damage and weaken the hard parts of the bones, causing fragile bones that are more likely to break.  
(See Symptoms of Multiple Myeloma to learn more about possible signs of this condition.)
Treatment for multiple myeloma can vary. People who are not experiencing symptoms may be closely watched without treatment. When treatment is given, it may include radiation therapy, medications, and bone marrow transplant. The specific choice of treatment depends on several factors, such as:
  • How far the disease has progressed (see Multiple Myeloma Stage)
  • The severity of symptoms
  • A person's overall health.
Kyprolis is used to treat people with multiple myeloma who have already received at least two other medications, including bortezomib (Velcade®) and an immunomodulatory agent, such as lenalidomide (Revlimid®) or thalidomide (Thalomid®). It is prescribed when multiple myeloma gets worse during or within 60 days of stopping the other medicines.
5 Easy Tips to Manage Visitors During Cancer Treatment

Kyprolis Chemotherapy Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2020 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.